Clinical Trial Update: Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of dimethyl fumarate on T cells in patients with relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: University Hospital Muenster | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: COMPLETED